Tryggvadóttir L - Search Results

1

Altered expression of HLA class I antigens in breast cancer: association with prognosis.

Gudmundsdóttir I, Gunnlaugur Jónasson J, Sigurdsson H, Olafsdóttir K, Tryggvadóttir L, Ogmundsdóttir HM. Gudmundsdóttir I, et al. Among authors: tryggvadottir l. Int J Cancer. 2000 Nov 20;89(6):500-5. doi: 10.1002/1097-0215(20001120)89:6<500::aid-ijc6>3.0.co;2-#. Int J Cancer. 2000. PMID: 11102894 Free article.

2

Reproductive factors and breast cancer risk in Iceland. A second cohort study.

Tulinius H, Sigvaldason H, Hrafnkelsson J, Olafsdóttir G, Tryggvadóttir L, Sigurösson K. Tulinius H, et al. Among authors: tryggvadottir l. Int J Cancer. 1990 Dec 15;46(6):972-5. doi: 10.1002/ijc.2910460604. Int J Cancer. 1990. PMID: 2249903

3

Familial and sporadic breast cancer cases in Iceland: a comparison related to ABO blood groups and risk of bilateral breast cancer.

Tryggvadottir L, Tulinius H, Robertson JM. Tryggvadottir L, et al. Int J Cancer. 1988 Oct 15;42(4):499-501. doi: 10.1002/ijc.2910420405. Int J Cancer. 1988. PMID: 3170024

4

Linkage to BRCA2 region in hereditary male breast cancer.

Thorlacius S, Tryggvadottir L, Olafsdottir GH, Jonasson JG, Ogmundsdottir HM, Tulinius H, Eyfjord JE. Thorlacius S, et al. Among authors: tryggvadottir l. Lancet. 1995 Aug 26;346(8974):544-5. doi: 10.1016/s0140-6736(95)91383-1. Lancet. 1995. PMID: 7658781

5

TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.

Thorlacius S, Thorgilsson B, Björnsson J, Tryggvadottir L, Börresen AL, Ogmundsdottir HM, Eyfjörd JE. Thorlacius S, et al. Among authors: tryggvadottir l. Eur J Cancer. 1995 Oct;31A(11):1856-61. doi: 10.1016/0959-8049(95)00399-4. Eur J Cancer. 1995. PMID: 8541113

6

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.

Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM, Eyfjörd JE. Thorlacius S, et al. Among authors: tryggvadottir l. Nat Genet. 1996 May;13(1):117-9. doi: 10.1038/ng0596-117. Nat Genet. 1996. PMID: 8673089

7

TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material.

Gretarsdottir S, Tryggvadottir L, Jonasson JG, Sigurdsson H, Olafsdottir K, Agnarsson BA, Ogmundsdottir H, Eyfjörd JE. Gretarsdottir S, et al. Among authors: tryggvadottir l. Br J Cancer. 1996 Aug;74(4):555-61. doi: 10.1038/bjc.1996.400. Br J Cancer. 1996. PMID: 8761369 Free PMC article.

8

Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis.

Valgardsdottir R, Tryggvadottir L, Steinarsdottir M, Olafsdottir K, Jonasdottir S, Jonasson JG, Ogmundsdottir HM, Eyfjörd JE. Valgardsdottir R, et al. Among authors: tryggvadottir l. APMIS. 1997 Feb;105(2):121-30. doi: 10.1111/j.1699-0463.1997.tb00550.x. APMIS. 1997. PMID: 9113074

9

Altered expression of E-cadherin in breast cancer. patterns, mechanisms and clinical significance.

Asgeirsson KS, Jónasson JG, Tryggvadóttir L, Olafsdóttir K, Sigurgeirsdóttir JR, Ingvarsson S, Ogmundsdóttir HM. Asgeirsson KS, et al. Among authors: tryggvadottir l. Eur J Cancer. 2000 Jun;36(9):1098-106. doi: 10.1016/s0959-8049(00)00062-9. Eur J Cancer. 2000. PMID: 10854942

10

GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene.

Gudmundsdottir K, Tryggvadottir L, Eyfjord JE. Gudmundsdottir K, et al. Among authors: tryggvadottir l. Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1169-73. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11700265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

333 results

Search Page